Methoxamine rectal (Norgine)

N/A

Report date: 2025/05/29 16:54:30

NME

Base Information

Drug NameMethoxamine rectal (Norgine)

Drug Alias Name1R,2S-methoxamine rectal (Norgine)1R, 2S-methoxamine hydrochloride (Norgine)1R,2S-methoxamine (Norgine)L-Erythro-methoxamine rectal (Norgine)NRL001 +[6]

ClassificationSmall molecules

Mechanisms of ActionAdrenergic receptor alpha-1 agonists

TargetsAdrenergic receptors alpha-1

Therapy Area/IndicationsEncopresis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNorgine Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNorgine

Active IndicationsN/A

Inactive IndicationsEncopresis

Other Information

ATC CodeN/A